Yield10 Bioscience, Inc. focuses on developing advanced traits in crops to enhance agricultural productivity, particularly in canola and corn. The company leverages its proprietary gene-editing technology to create higher-yielding crop varieties, which is critical as global food demand rises.
Business Overview
Yield10 generates revenue primarily through licensing its patented genetic traits to agricultural companies. The company has a unique competitive advantage due to its proprietary technology that allows for precise gene editing, which can lead to significant yield improvements in crops.
Advancements in gene-editing technology
Partnership agreements with major agricultural firms
Regulatory approvals for new crop varieties
Market demand for sustainable agricultural solutions
Risk Factors
Regulatory changes affecting gene-editing technologies
Technological disruption from competing agricultural biotech firms
Emergence of alternative agricultural technologies
Market share loss to larger agricultural firms with more resources
High negative margins indicating financial instability
Limited cash flow impacting operational sustainability
Macro Sensitivity
moderate - The agricultural sector is somewhat insulated from economic cycles, but demand for agricultural inputs can be affected by GDP growth and consumer spending on food.
Higher interest rates can increase financing costs for R&D and operational expansion, potentially impacting profitability and valuation multiples.
minimal - The company does not rely heavily on credit for operations.
Profile
growth - Investors looking for innovative agricultural solutions and long-term growth potential.
high - The stock has shown significant volatility, particularly with a 93.2% decline over the past year.
Explore More
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
